Literature DB >> 389147

Oligodendrocyte staining by multiple sclerosis serum is nonspecific.

U Traugott, S Snyder, C S Raine.   

Abstract

The immunofluorescent staining properties of 65 serum samples from 54 patients with multiple sclerosis (MS), 63 samples from 55 patients with other neurological diseases (OND), and sera from 14 healthy normal individuals were examined on frozen sections of bovine and human brain. When tested on bovine brain sections, positive oligodendrocyte staining was present in 63% of MS sera, 43% of OND sera, and 29% of normal sera. The percentages were lower with human brain tissue. Astrocyte and myelin staining was common. F(ab')2 fragments purified from selected positive and negative MS and control sera gave no staining, though IgG fractions from the same sera prior to pepsin digestion gave positive staining. When tested against antihuman IgM and IgA conjugates, the same positive sera and their IgG-depleted globulin fractions gave minimal or no staining. These results indicate that oligodendrocyte staining is not specific for MS, is not due to specific antibody, and is probably the result of nonspecific binding to Fc receptors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 389147     DOI: 10.1002/ana.410060104

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  11 in total

Review 1.  A review of the etiology of multiple sclerosis.

Authors:  V Vella
Journal:  Ital J Neurol Sci       Date:  1984-12

2.  Shared antigenic determinants between brain and thymus-derived lymphocytes in dogs.

Authors:  S Krakowka; A L Wallace; A Koestner
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

3.  Antibody to myelin basic protein in extracts of multiple sclerosis brain.

Authors:  C C Bernard; V B Randell; L B Horvath; P R Carnegie; I R Mackay
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

4.  Analysis of immunoglobulin G in multiple sclerosis brain: quantitative and isoelectric focusing studies.

Authors:  P Glynn; H M Gilbert; J Newcombe; M L Cuzner
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

Review 5.  B cells in multiple sclerosis.

Authors:  Mark P Burgoon; Donald H Gilden; Gregory P Owens
Journal:  Front Biosci       Date:  2004-01-01

6.  Antibodies against viruses and structural brain components in oligoclonal IgG obtained from multiple sclerosis brain.

Authors:  B Roström
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

7.  Do patients with demyelinating disease have antibodies against human glial cells in their sera?

Authors:  P G Kennedy; R P Lisak
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-02       Impact factor: 10.154

8.  Immunoglobulins in demyelinating lesions in canine distemper encephalitis. An immunohistological study.

Authors:  M Vandevelde; R Fankhauser; F Kristensen; B Kristensen
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

9.  Rat CNS cell culture. Enhancement of neuronal survival and delay of glial proliferation by serum from patients with multiple sclerosis. A morphological study.

Authors:  G Savettieri; D Ferraro; A Chiarini; A Cestelli
Journal:  Ital J Neurol Sci       Date:  1984-09

Review 10.  Abnormalities of serum and plasma components in patients with multiple sclerosis.

Authors:  H C Ford
Journal:  Clin Biochem       Date:  1985-02       Impact factor: 3.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.